2m 2m 2m 2m 2m 2m 2m
ALVOTECH (ALVO)
NASDAQ
$3.70-$0.005 (-0.14%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.3BMarket Cap
- -59.87%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ALVOTECH (ALVO)
$3.70-$0.005 (-0.14%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 159.7M +10.64% | 144.4M +1,431.11% | 9.4M -47.44% | 17.9M N/A | |
Cost of Revenue | 235.6M +27.12% | 185.3M +15.20% | 160.9M +150.96% | 64.1M N/A | |
Gross Profit | 14.1M +134.45% | -40.9M -72.97% | -151.4M +228.08% | -46.2M N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -184.2M +7.52% | -171.3M -18.74% | -210.8M +16.72% | -180.6M N/A | |
Depreciation and Amortization Expense | 37.9M +20.93% | 31.3M +29.29% | 24.2M +18.62% | 20.4M N/A | |
Total Operating Expenses | 90.9M +38.40% | 65.7M -14.17% | 76.6M -59.00% | 186.7M N/A | |
Operating Profit | 78.2M +12.30% | 69.6M +119.63% | -354.9M +2.43% | -346.4M N/A | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -151,000 N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -151,000 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | 151,000 N/A | |
Income before Taxes | 27.9M +112.04% | -231.9M -57.98% | -551.7M +7.43% | -513.6M N/A | |
Income Taxes | 108.4M +658.19% | 14.3M +114.40% | -99.3M +160.90% | -38.1M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 27.9M +112.04% | -231.9M -57.98% | -551.7M +7.43% | -513.6M N/A | |
Net Income from Continuing Operations Applicable to Common | 27.9M +112.04% | -231.9M -57.98% | -551.7M +7.43% | -513.6M N/A | |
Basic EPS and Net Income | 0.10 +111.49% | -0.87 -64.20% | -2.43 -6.54% | -2.60 N/A | |
Diluted EPS and Net Income | 0.10 +111.49% | -0.87 -64.20% | -2.43 -6.54% | -2.60 N/A | |
Basic Weighted Average Shares | 289.7M +8.14% | 267.9M +17.90% | 227.3M +14.94% | 197.7M N/A | |
Diluted Weighted Average Shares | 289.7M +8.14% | 267.9M +17.90% | 227.3M +14.94% | 197.7M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 172.4M +235.15% | 51.4M +360.95% | 11.2M -83.20% | 66.4M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 172.4M +235.15% | 51.4M +360.95% | 11.2M -83.20% | 66.4M N/A | |
Total Current Assets | 574.0M +26.15% | 455.0M +133.53% | 194.8M -15.56% | 230.7M N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 356.4M +25.25% | 284.5M +20.17% | 236.8M +7.34% | 220.6M N/A | |
Total Long-Term Assets | 913.1M +19.14% | 766.4M +1.47% | 755.2M +26.36% | 597.7M N/A | |
Total Assets | 1.5B +21.75% | 1.2B +28.56% | 950.1M +14.68% | 828.4M N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 304.1M +57.23% | 193.4M -25.89% | 260.9M +55.98% | 167.3M N/A | |
Total Long-Term Debt | 102.4M +31.57% | 77.8M -20.26% | 97.6M +37.02% | 71.2M N/A | |
Total Long-Term Liabilities | 1.5B +1.86% | 1.4B -11.15% | 1.6B +32.32% | 1.2B N/A | |
Total Liabilities | 1.8B +8.41% | 1.6B -13.20% | 1.9B +35.16% | 1.4B N/A | |
Retained Earnings | -2.4B -1.15% | -2.4B +10.51% | -2.2B +33.36% | -1.7B N/A | |
Total Stockholders Equity | -284.5M -31.08% | -412.8M -55.73% | -932.5M +65.21% | -564.4M N/A | |
Total Shares Outstanding | 312.0M +3.38% | 301.8M +13.11% | 266.8M +23,447.31% | 1.1M N/A | |
Cash Flow | |||||
Cash from Operating Activities | -50.2M -78.81% | -236.8M -24.13% | -312.2M -0.07% | -312.4M N/A | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -104.2M +452.34% | -18.9M -59.28% | -46.3M -27.07% | -63.5M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 270.8M -8.90% | 297.3M -1.33% | 301.3M -29.09% | 424.9M N/A | |
Financials Ratio | |||||
Gross Margin | -47.46% +67.43% | -28.34% -98.23% | -1,605.79% N/A | N/A N/A | |
Operating Margin | 48.96% +1.50% | 48.24% +101.28% | -3,763.10% N/A | N/A N/A | |
Return on Assets | 2.06% +109.65% | -21.36% -65.58% | -62.04% N/A | N/A N/A | |
Return on Equity | -8.01% -123.23% | 34.47% -53.24% | 73.72% N/A | N/A N/A | |
Revenue Growth | 10.64% -99.26% | 1,431.11% +3,116.94% | -47.44% N/A | N/A N/A | |
Current Ratio | 1.89 -19.77% | 2.35 +215.09% | 0.75 N/A | N/A N/A | |
Cash Ratio | 0.57 +113.16% | 0.27 +521.26% | 0.04 N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow